Panbela Therapeutics Inc Share Price Today: Live Updates & Key Insights
Panbela Therapeutics Inc share price today is $1.11, up -9.76%. The stock opened at $1.23 against the previous close of $1.23, with an intraday high of $1.28 and low of $1.08.
Panbela Therapeutics Inc Share Price Chart
Panbela Therapeutics Inc
Panbela Therapeutics Inc Share Price Performance
Panbela Therapeutics Inc Institutional Holdings
Panbela Therapeutics Inc Market Status
Panbela Therapeutics Inc Fundamentals
Market Cap 3.93 M
PB Ratio 3.2198
PE Ratio 0.0
Enterprise Value 8.64 M
Total Assets 4.98 M
Volume 834539
Panbela Therapeutics Inc Company Financials
About Panbela Therapeutics Inc & investment objective
Company Information Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, develops disruptive therapeutics for the treatment of patients with urgent unmet medical needs. The company's lead product candidates are Ivospemin (SBP-101), which has completed Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma; FlynpoviTM, a combination of eflornithine (CPP-1X) and sulindac which is in Phase III clinical trials; and Eflornithine, an enzyme-activated irreversible inhibitor of the enzyme ornithine decarboxylase. It has a research agreement with the Johns Hopkins University School of Medicine for the development of Panbela's investigative agent ivospemin. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Organisation Biotechnology
Employees 6
Industry Biotechnology
CEO Dr. Jennifer K. Simpson CRNP, M.S.N., Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Panbela Therapeutics Inc FAQs
What is the share price of Panbela Therapeutics Inc today?
The current share price of Panbela Therapeutics Inc is $1.11.
Can I buy Panbela Therapeutics Inc shares in India?
Yes, Indian investors can buy Panbela Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Panbela Therapeutics Inc shares in India?
You can easily invest in Panbela Therapeutics Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Panbela Therapeutics Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Panbela Therapeutics Inc.
Can I buy fractional shares of Panbela Therapeutics Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Panbela Therapeutics Inc?
Panbela Therapeutics Inc has a market cap of $3.93 M.
In which sector does Panbela Therapeutics Inc belong?
Panbela Therapeutics Inc operates in the Biotechnology sector.
What documents are required to invest in Panbela Therapeutics Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Panbela Therapeutics Inc?
The PE ratio of Panbela Therapeutics Inc is N/A and the PB ratio is 3.22.